cholinoceptor

cholinoceptor

 [ko″lin-o-sep´ter]
cholinergic receptor.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.
References in periodicals archive ?
During the past 8 years she had been classified as having appendicitis pancreatitis ischemic enteropathy or irritable bowel syndrome and treated with H1-receptor antagonists glucocorticoids cholinoceptor blocking drugs etc.
Like the nicotinic cholinoceptor, it is a pentameric structure and modern techniques of genetic engineering (in particular the production of "knock-out" and "knock-in" mice) have been employed to determine the influences of those five protein strands on the properties of the receptors.
Aging-related alteration in the contractile responses to acetylcholine, muscarinic cholinoceptors and cholinesterase activities in jejunum and colon of the male Fischer 344 rats.
postulate that early agonistic-promoting activation in two types of muscarinic acetylcholine receptors (mAChRs) M1 and M3 initiated by antibodies binds to persistently activate cerebral frontal cholinoceptors. This activity might induce desensitization, internalization, and/or intracellular degradation of the mAChR, leading to a progressive decrease of cerebral M1 and M3 mAChR expression and activity.
Roeske, "Effects of chemical sympathectomy with 6-hydroxydopamine on aand [beta]-adrenoceptors and muscarinic cholinoceptors in rat kidney," European Journal of Pharmacology, vol.
Muscarinic cholinoceptors in the ventromedial hypothalamic nucleus facilitate tail heat loss during physical exercise.
Succinylcholine, cholinoceptors and catecholamines: Proposed mechanism of early adverse haemodynamic reactions.
Involvement of cholinoceptors in cadmium-induced endothelial dysfunction.
Other pharmacologic effects include the following: endothelium relaxation mediated by inhibition of 3', 5'-cyclic GMP (guanosine monophosphate) phosphodiesterase; inhibition of age-related loss of muscarinergic cholinoceptors and a-adrenoceptors; and stimulation of choline uptake in the hippocampus.
Thus, drugs with an affinity for muscarinic cholinoceptors prolong the latency and reduce the amplitude [16], whereas drugs reducing the sympathetic input prolong the recovery time [17].